386 related articles for article (PubMed ID: 1671759)
21. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients.
Lau LC; Tan PH; Chong TW; Foo KT; Yip S
Cancer Genet Cytogenet; 2007 May; 175(1):1-7. PubMed ID: 17498551
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic analysis in renal cell carcinoma: correlation with tumor aggressiveness.
Weaver DJ; Michalski K; Miles J
Cancer Res; 1988 May; 48(10):2887-9. PubMed ID: 3359445
[TBL] [Abstract][Full Text] [Related]
24. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
[TBL] [Abstract][Full Text] [Related]
25. Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data.
Höglund M; Gisselsson D; Soller M; Hansen GB; Elfving P; Mitelman F
Cancer Genet Cytogenet; 2004 Aug; 153(1):1-9. PubMed ID: 15325087
[TBL] [Abstract][Full Text] [Related]
26. [Genetics of renal tumors].
Oláh E; Jakab Z; Balogh E
Orv Hetil; 2001 Jul; 142(26):1367-73. PubMed ID: 11478032
[TBL] [Abstract][Full Text] [Related]
27. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas.
Shridhar V; Wang L; Rosati R; Paradee W; Shridhar R; Mullins C; Sakr W; Grignon D; Miller OJ; Sun QC; Petros J; Smith DI
Oncogene; 1997 Mar; 14(11):1269-77. PubMed ID: 9178887
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
[TBL] [Abstract][Full Text] [Related]
29. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
30. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases.
Kovacs G
Am J Pathol; 1989 Jan; 134(1):27-34. PubMed ID: 2913826
[TBL] [Abstract][Full Text] [Related]
31. Assessing genetic heterogeneity of renal cell tumors.
Mirghomizadeh F; Kupka S; Blin N
Anticancer Res; 1999; 19(2C):1467-70. PubMed ID: 10365125
[TBL] [Abstract][Full Text] [Related]
32. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes.
Hughson MD; Meloni A; Dougherty S; Silva FG; Sandberg AA
Cancer Genet Cytogenet; 1996 Apr; 87(2):133-9. PubMed ID: 8625259
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas.
Kovacs A; Storkel S; Thoenes W; Kovacs G
J Pathol; 1992 Jul; 167(3):273-7. PubMed ID: 1381433
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis.
Gunawan B; Huber W; Holtrup M; von Heydebreck A; Efferth T; Poustka A; Ringert RH; Jakse G; Füzesi L
Cancer Res; 2001 Nov; 61(21):7731-8. PubMed ID: 11691785
[TBL] [Abstract][Full Text] [Related]
35. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
[TBL] [Abstract][Full Text] [Related]
36. Accumulation of genetic alterations and progression of primary breast cancer.
Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
[TBL] [Abstract][Full Text] [Related]
37. Numerical chromosomal aberrations in papillary renal cortical tumors: relationship with histopathologic features.
Henke RP; Erbersdobler A
Virchows Arch; 2002 Jun; 440(6):604-9. PubMed ID: 12070600
[TBL] [Abstract][Full Text] [Related]
38. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis.
van den Berg A; Hulsbeek MF; de Jong D; Kok K; Veldhuis PM; Roche J; Buys CH
Genes Chromosomes Cancer; 1996 Jan; 15(1):64-72. PubMed ID: 8824727
[TBL] [Abstract][Full Text] [Related]
39. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
[TBL] [Abstract][Full Text] [Related]
40. Precancerous lesions in the kidney.
Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
